KIR3DL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Note that both the proportion of cells expressing Eomes among the KIR/NKG2A(+) CD8(+) T cell subset (Figure S1 in Supplementary Material) and the expression levels (Figure 1C) were significantly reduced in CML-CP patients [frequency: 26.3% ± 3.2 (n = 6) and mean fluorescence intensity (MFI): 2.17 ± 0.25 (n = 6), respectively] as compared to HD [frequency: 46.5% ± 4.6 (n = 14) and MFI: 3.95 ± 0.52 (n = 15), respectively].